DaVita Clinical Research, Minneapolis, MN.
Relypsa Inc, Redwood City, CA.
Am J Kidney Dis. 2017 Jul;70(1):21-29. doi: 10.1053/j.ajkd.2016.10.024. Epub 2017 Jan 19.
Hyperkalemia is common among hemodialysis patients and is associated with morbidity and mortality. The long interdialytic interval is likewise associated with adverse outcomes. However, the interplay among serum potassium, dialysis cycle phase, and clinical outcomes has not been examined.
Retrospective observational study.
SETTING & PARTICIPANTS: 52,734 patients receiving in-center hemodialysis at a large dialysis organization during 2010 and 2011 contributed 533,889 potassium measurements (230,634 on Monday; 285,522 on Wednesday; 17,733 on Friday).
Serum potassium concentration, day of the week of potassium measurement.
Death, hospitalization, emergency department (ED) visit.
There was a significant association between higher serum potassium and risk of hospitalization within 96 hours that was of greater magnitude on Fridays (389 hospitalizations) than Mondays or Wednesdays (4,582 and 4,629 hospitalizations, respectively; P for interaction = 0.008). Serum potassium of 5.5 to <6.0 (vs the referent category of 4.0-<4.5 mEq/L) was associated with increased risk of hospitalization on Fridays, with an adjusted OR of 1.68 (95% CI, 1.22-2.30). However, serum potassium of 5.5 to <6.0 mEq/L was associated with only mild elevation of risk on Mondays and no significantly increased risk on Wednesdays (adjusted ORs of 1.12 [95% CI, 1.00-1.24] and 1.04 [95% CI, 0.94-1.16], respectively). Associations of elevated serum potassium (6.0-<6.5 mEq/L or greater) with death and ED visit were significant, but did not differ based on day of the week.
There were insufficient observations to detect effect modification by day of the week for deaths, ED visits, and specific causes of hospitalizations. Confounding may have influenced results.
Higher serum potassium is associated with increased short-term risk of hospitalization, ED visit, and death. The association between serum potassium and hospitalization risk is modified by day of the week, consistent with a contribution of accumulated potassium to adverse outcomes following the long interdialytic interval. Further work is needed to determine whether directed interventions ameliorate this risk.
高钾血症在血液透析患者中很常见,与发病率和死亡率有关。长的透析间期同样与不良结果有关。然而,血清钾、透析周期阶段和临床结果之间的相互作用尚未被研究。
回顾性观察性研究。
2010 年和 2011 年期间,一家大型透析机构的 52734 名接受中心血液透析的患者提供了 533889 份血钾测量值(周一 230634 份;周三 285522 份;周五 17733 份)。
血清钾浓度,钾测量的星期几。
血清钾升高与 96 小时内住院风险显著相关,周五的风险更大(389 例住院),高于周一或周三(分别为 4582 和 4629 例住院;P 交互作用=0.008)。血清钾 5.5 至<6.0(与参考类别 4.0-<4.5mEq/L 相比)与周五住院风险增加相关,校正后的比值比为 1.68(95%CI,1.22-2.30)。然而,血清钾 5.5 至<6.0mEq/L 仅与周一的风险轻度升高相关,周三的风险无显著增加(校正比值比分别为 1.12(95%CI,1.00-1.24)和 1.04(95%CI,0.94-1.16))。血清钾升高(6.0-<6.5mEq/L 或更高)与死亡和急诊就诊的相关性显著,但与星期几无关。
由于缺乏观察,无法检测到死亡、急诊就诊和特定住院原因的星期几的效应修饰。混杂因素可能影响了结果。
血清钾升高与短期住院、急诊就诊和死亡的风险增加有关。血清钾与住院风险之间的关联受星期几的影响,这与长透析间期后累积钾对不良结果的贡献一致。需要进一步的工作来确定有针对性的干预措施是否可以改善这种风险。